UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Specific adverse outcomes associated with selective serotonin reuptake inhibitors use in COVID-19 patients might be potentiated by remdesivir use

Journal of psychopharmacology (Oxford), 2024-04, Vol.38 (4), p.395-403

2024

Volltextzugriff (PDF)

Corticosteroid Dosing Level, Incidence and Profile of Bacterial Blood Stream Infections in Hospitalized COVID-19 Patients

Viruses, 2024-01, Vol.16 (1), p.86

2024

Volltextzugriff (PDF)

Remdesivir might induce changes in electrocardiogram beyond bradycardia in patients with coronavirus disease 2019—The pilot study

Journal of medical virology, 2021-10, Vol.93 (10), p.5724-5725

2021

Volltextzugriff (PDF)

Clinical and prognostic significance of C-reactive protein to albumin ratio in hospitalized coronavirus disease 2019 (COVID-19) patients: Data on 2309 patients from a tertiary center and validation in an independent cohort

Wiener Klinische Wochenschrift, 2022-05, Vol.134 (9-10), p.377-384

2022

Volltextzugriff (PDF)

Relative Bradycardia and Tachycardia and Their Associations with Adverse Outcomes in Hospitalized COVID-19 Patients

Reviews in cardiovascular medicine, 2023-08, Vol.24 (8), p.238

2023

Volltextzugriff (PDF)

Remdesivir-associated bradycardia might be a sign of good prognosis in COVID-19 patients

Clinical microbiology and infection, 2022-04, Vol.28 (4), p.619-619

2022

Volltextzugriff (PDF)

Real-life experience with remdesivir for treatment of hospitalized coronavirus disease 2019 patients: matched case-control study from a large tertiary hospital registry

Croatian medical journal, 2022-12, Vol.63 (6), p.536-543

2022

Volltextzugriff (PDF)

P1563: REMDESIVIR USE IN SEVERE AND CRITICAL COVID‐19 PATIENTS MIGHT BE ASSOCIATED WITH LOWER INCIDENCE OF ARTERIAL THROMBOTIC EVENTS

HemaSphere, 2023-08, Vol.7 (S3), p.e79769f1-n/a

2023

Volltextzugriff (PDF)

Bradycardia during remdesivir treatment might be associated with improved survival in patients with COVID-19: a retrospective cohort study on 473 patients from a tertiary centre

Postgraduate medical journal, 2022-07, Vol.98 (1161), p.501-502

2022

Volltextzugriff (PDF)

Effects of Long-Term Multimodal Psychosocial Treatment on Antipsychotic-Induced Metabolic Changes in Patients With First Episode Psychosis

Frontiers in psychiatry, 2018-10, Vol.9, p.488-488

2018

Volltextzugriff (PDF)

Patterns of corticosteroid use among remdesivir and matched patients and associated clinical outcomes in hospitalized COVID-19 patients

Expert opinion on pharmacotherapy, 2024-02, Vol.25 (2), p.215-222

2024

Volltextzugriff (PDF)

Negative Prognostic Associations of Selective Serotonin Reuptake Inhibitors Use in Hospitalized COVID-19 Patients and Potential Contribution of Cardiovascular Comorbidities

Pharmacology, 2024-07, p.1-8

2024

Volltextzugriff (PDF)

Remdesivir use in COVID-19 patients might predispose bacteremia, matched case-control analysis

The Journal of infection, 2022-08, Vol.85 (2), p.174-211

2022

Volltextzugriff (PDF)

Remdesivir use in severe and critical COVID-19 patients might be associated with lower incidence of arterial thrombotic events

The American journal of emergency medicine, 2023-08, Vol.70, p.41-45

2023

Volltextzugriff (PDF)

Risks associated with prior oral anticoagulation use in hospitalized COVID-19 patients – A retrospective cohort study on 5392 patients from a tertiary centre

International journal of cardiology, 2023-02, Vol.372, p.144-149

2023

Volltextzugriff (PDF)

Atrial fibrillation in COVID-19 patients receiving remdesivir, matched case-control analysis

The American journal of emergency medicine, 2022-09, Vol.59, p.182-183

2022

Volltextzugriff (PDF)

Gradual increase in red cell distribution width is similarly prognostic for in‐hospital mortality in both anemic and non‐anemic COVID‐19 patients

Journal of medical virology, 2022-08, Vol.94 (8), p.3509-3511

2022

Volltextzugriff (PDF)

Remdesivir use in atrial fibrillation

Cardiologia Croatica, 2022-11, Vol.17 (9-10), p.172-172

2022

Volltextzugriff (PDF)

“Rheumatoid armor”: a case of constrictive pericarditis

Cardiologia Croatica, 2023-04, Vol.18 (5-6), p.180-180

2023

Volltextzugriff (PDF)

Clinical outcomes of atrial fibrillation and acute myocardial infarction in long-term follow up

Cardiologia Croatica, 2022-11, Vol.17 (9-10), p.155-155

2022

Volltextzugriff (PDF)

Design, synthesis and biological evaluation of novel benzimidazole amidines as potent multi-target inhibitors for the treatment of non-small cell lung cancer

European journal of medicinal chemistry, 2018-01, Vol.143, p.1616-1634

2018

Volltextzugriff (PDF)

Novel Bis- and Mono-Pyrrolo[2,3-d]pyrimidine and Purine Derivatives: Synthesis, Computational Analysis and Antiproliferative Evaluation

Molecules (Basel, Switzerland), 2021-06, Vol.26 (11), p.3334

2021

Volltextzugriff (PDF)

Synthesis and Anti-Proliferative Effects of Mono- and Bis-Purinomimetics Targeting Kinases

International journal of molecular sciences, 2017-11, Vol.18 (11), p.2292

2017

Volltextzugriff (PDF)

Small molecule purine and pseudopurine derivatives: synthesis, cytostatic evaluations and investigation of growth inhibitory effect in non-small cell lung cancer A549

Journal of enzyme inhibition and medicinal chemistry, 2018-01, Vol.33 (1), p.271-285

2018

Volltextzugriff (PDF)

1 – 24 von 24

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(21)
Mit Volltextzugriff
(18)

Publikationsform

Artikel
(24)

Sprache

Englisch
(24)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(18)
Science & Technology
(18)
Covid-19
(12)
Humans
(9)
Retrospective Studies
(6)
Sars-Cov-2
(6)
Comorbidity
(5)
Coronaviruses
(5)
Adenosine Monophosphate - Analogs & Derivatives
(4)
Alanine - Analogs & Derivatives
(4)
Antiviral Drugs
(4)
Covid-19 Drug Treatment
(4)
Hospitalization
(4)
Letter To The Editor
(4)
1,2,3-Triazole
(3)
Antiviral Agents - Adverse Effects
(3)
Bacteremia
(3)
Cardiac Arrhythmia
(3)
General & Internal Medicine
(3)
Infectious Diseases
(3)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Specific adverse outcomes associated with selective serotonin reuptake inhibitors use in COVID-19 patients might be potentiated by remdesivir use

Corticosteroid Dosing Level, Incidence and Profile of Bacterial Blood Stream Infections in Hospitalized COVID-19 Patients

Remdesivir might induce changes in electrocardiogram beyond bradycardia in patients with coronavirus disease 2019—The pilot study

Clinical and prognostic significance of C-reactive protein to albumin ratio in hospitalized coronavirus disease 2019 (COVID-19) patients: Data on 2309 patients from a tertiary center and validation in an independent cohort

Relative Bradycardia and Tachycardia and Their Associations with Adverse Outcomes in Hospitalized COVID-19 Patients

Remdesivir-associated bradycardia might be a sign of good prognosis in COVID-19 patients

Real-life experience with remdesivir for treatment of hospitalized coronavirus disease 2019 patients: matched case-control study from a large tertiary hospital registry

P1563: REMDESIVIR USE IN SEVERE AND CRITICAL COVID‐19 PATIENTS MIGHT BE ASSOCIATED WITH LOWER INCIDENCE OF ARTERIAL THROMBOTIC EVENTS

Bradycardia during remdesivir treatment might be associated with improved survival in patients with COVID-19: a retrospective cohort study on 473 patients from a tertiary centre

Effects of Long-Term Multimodal Psychosocial Treatment on Antipsychotic-Induced Metabolic Changes in Patients With First Episode Psychosis

Patterns of corticosteroid use among remdesivir and matched patients and associated clinical outcomes in hospitalized COVID-19 patients

Negative Prognostic Associations of Selective Serotonin Reuptake Inhibitors Use in Hospitalized COVID-19 Patients and Potential Contribution of Cardiovascular Comorbidities

Remdesivir use in COVID-19 patients might predispose bacteremia, matched case-control analysis

Remdesivir use in severe and critical COVID-19 patients might be associated with lower incidence of arterial thrombotic events

Risks associated with prior oral anticoagulation use in hospitalized COVID-19 patients – A retrospective cohort study on 5392 patients from a tertiary centre

Atrial fibrillation in COVID-19 patients receiving remdesivir, matched case-control analysis

Gradual increase in red cell distribution width is similarly prognostic for in‐hospital mortality in both anemic and non‐anemic COVID‐19 patients

Remdesivir use in atrial fibrillation

“Rheumatoid armor”: a case of constrictive pericarditis

Clinical outcomes of atrial fibrillation and acute myocardial infarction in long-term follow up

Design, synthesis and biological evaluation of novel benzimidazole amidines as potent multi-target inhibitors for the treatment of non-small cell lung cancer

Novel Bis- and Mono-Pyrrolo[2,3-d]pyrimidine and Purine Derivatives: Synthesis, Computational Analysis and Antiproliferative Evaluation

Synthesis and Anti-Proliferative Effects of Mono- and Bis-Purinomimetics Targeting Kinases

Small molecule purine and pseudopurine derivatives: synthesis, cytostatic evaluations and investigation of growth inhibitory effect in non-small cell lung cancer A549

Suchergebnisse filtern